INVE

SEC source: 0001781002-20-000027 · primary_doc.xml · nonDerivative · entry 4

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,114,989

F3 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.085 to $4.15 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F4 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

F5 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts that directly hold these securities. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. 21 April Fund, Ltd. owns 1,520,704 shares and 21 April Fund, LP owns 399,285 shares respectively of these 2,114,989 shares reported in this form.

SEC source: 0001781002-20-000027 · primary_doc.xml · nonDerivative · entry 3

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,109,488

F2 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.39 to $4.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F4 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

F5 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts that directly hold these securities. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. 21 April Fund, Ltd. owns 1,520,704 shares and 21 April Fund, LP owns 399,285 shares respectively of these 2,114,989 shares reported in this form.

SEC source: 0001781002-20-000027 · primary_doc.xml · nonDerivative · entry 2

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,102,800

F1 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.45 to $4.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F4 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

F5 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts that directly hold these securities. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. 21 April Fund, Ltd. owns 1,520,704 shares and 21 April Fund, LP owns 399,285 shares respectively of these 2,114,989 shares reported in this form.

SEC source: 0000899243-20-006861 · doc4.xml · nonDerivative · entry 2

HUMPHREYS STEVEN · CIK 0001229295 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,165

SEC source: 0000899243-20-006861 · doc4.xml · nonDerivative · entry 1

HUMPHREYS STEVEN · CIK 0001229295 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,050

F1 · shares: Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan in lieu of salary. The award is fully vested on the date of grant.

SEC source: 0001781002-20-000027 · primary_doc.xml · nonDerivative · entry 1

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,089,588

F4 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

F5 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts that directly hold these securities. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. 21 April Fund, Ltd. owns 1,520,704 shares and 21 April Fund, LP owns 399,285 shares respectively of these 2,114,989 shares reported in this form.

SEC source: 0001781002-20-000026 · primary_doc.xml · nonDerivative · entry 3

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,089,488

F1 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. On 02/20/2020, prices ranged from $4.93 to $4.95 per share, inclusive. On 02/21/2020, prices ranged from $4.985 to $4.99 per share, inclusive. On 02/24/2020, prices ranged from $4.67 to $4.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

F3 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts that directly hold these securities. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. 21 April Fund, Ltd. owns 1,502,853 shares and 21 April Fund, LP owns 391,635 shares respectively of these 2,089,488 shares reported in this form.

SEC source: 0001781002-20-000026 · primary_doc.xml · nonDerivative · entry 2

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,073,275

F1 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. On 02/20/2020, prices ranged from $4.93 to $4.95 per share, inclusive. On 02/21/2020, prices ranged from $4.985 to $4.99 per share, inclusive. On 02/24/2020, prices ranged from $4.67 to $4.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

F3 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts that directly hold these securities. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. 21 April Fund, Ltd. owns 1,502,853 shares and 21 April Fund, LP owns 391,635 shares respectively of these 2,089,488 shares reported in this form.

SEC source: 0001781002-20-000026 · primary_doc.xml · nonDerivative · entry 1

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,072,175

F1 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. On 02/20/2020, prices ranged from $4.93 to $4.95 per share, inclusive. On 02/21/2020, prices ranged from $4.985 to $4.99 per share, inclusive. On 02/24/2020, prices ranged from $4.67 to $4.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

F3 · ownership.nature: This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts that directly hold these securities. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. 21 April Fund, Ltd. owns 1,502,853 shares and 21 April Fund, LP owns 391,635 shares respectively of these 2,089,488 shares reported in this form.

SEC source: 0000899243-20-004947 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,557

F1 · balance_after: Includes an aggregate of 68,438 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0001781002-20-000004 · primary_doc.xml · nonDerivative · entry 5

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,066,339

F1 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

SEC source: 0001781002-20-000006 · primary_doc.xml · nonDerivative · entry 5

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,066,339

F7 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.825 to $4.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Total amount of securities reported in item 5 does not include previously reported 5,000,000 of Series B Convertible Preferred shares.

F3 · ownership.nature: The shares of Common Stock reported herein are indirectly beneficially owned by Bleichroeder, LP (Bleichroeder), a Delaware limited partnership, an investment adviser registered under the Investment Advisers Act of 1940. Bleichroeder is the registered investment adviser to Biotechnology Master Fund, Ltd. as well as to 21 April Fund, LP and 21 April Fund, Ltd. (collectively, the "Funds"). The shares of Common Stock reported herein are directly held by the Funds and other managed accounts. Bleichroeder disclaims beneficial ownership of the shares of Common Stock held directly by the Funds and other managed accounts except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder is the beneficial owner of any such securities.

SEC source: 0001781002-20-000004 · primary_doc.xml · nonDerivative · entry 4

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,056,226

F1 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

SEC source: 0001781002-20-000004 · primary_doc.xml · nonDerivative · entry 3

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,048,004

F1 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

SEC source: 0001781002-20-000006 · primary_doc.xml · nonDerivative · entry 4

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,056,226

F6 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.805 to $4.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Total amount of securities reported in item 5 does not include previously reported 5,000,000 of Series B Convertible Preferred shares.

F3 · ownership.nature: The shares of Common Stock reported herein are indirectly beneficially owned by Bleichroeder, LP (Bleichroeder), a Delaware limited partnership, an investment adviser registered under the Investment Advisers Act of 1940. Bleichroeder is the registered investment adviser to Biotechnology Master Fund, Ltd. as well as to 21 April Fund, LP and 21 April Fund, Ltd. (collectively, the "Funds"). The shares of Common Stock reported herein are directly held by the Funds and other managed accounts. Bleichroeder disclaims beneficial ownership of the shares of Common Stock held directly by the Funds and other managed accounts except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder is the beneficial owner of any such securities.

SEC source: 0001781002-20-000006 · primary_doc.xml · nonDerivative · entry 3

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,048,004

F5 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.90 to $5.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Total amount of securities reported in item 5 does not include previously reported 5,000,000 of Series B Convertible Preferred shares.

F3 · ownership.nature: The shares of Common Stock reported herein are indirectly beneficially owned by Bleichroeder, LP (Bleichroeder), a Delaware limited partnership, an investment adviser registered under the Investment Advisers Act of 1940. Bleichroeder is the registered investment adviser to Biotechnology Master Fund, Ltd. as well as to 21 April Fund, LP and 21 April Fund, Ltd. (collectively, the "Funds"). The shares of Common Stock reported herein are directly held by the Funds and other managed accounts. Bleichroeder disclaims beneficial ownership of the shares of Common Stock held directly by the Funds and other managed accounts except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder is the beneficial owner of any such securities.

SEC source: 0001781002-20-000004 · primary_doc.xml · nonDerivative · entry 2

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,034,893

F1 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

SEC source: 0001781002-20-000004 · primary_doc.xml · nonDerivative · entry 1

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,924,893

F1 · balance_after: Total amount of securities reported in item 5 does not includes previously reported 5,000,000 of Series B Convertible Preferred shares.

SEC source: 0001781002-20-000006 · primary_doc.xml · nonDerivative · entry 2

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,034,893

F4 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.795 to $5.10 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Total amount of securities reported in item 5 does not include previously reported 5,000,000 of Series B Convertible Preferred shares.

F3 · ownership.nature: The shares of Common Stock reported herein are indirectly beneficially owned by Bleichroeder, LP (Bleichroeder), a Delaware limited partnership, an investment adviser registered under the Investment Advisers Act of 1940. Bleichroeder is the registered investment adviser to Biotechnology Master Fund, Ltd. as well as to 21 April Fund, LP and 21 April Fund, Ltd. (collectively, the "Funds"). The shares of Common Stock reported herein are directly held by the Funds and other managed accounts. Bleichroeder disclaims beneficial ownership of the shares of Common Stock held directly by the Funds and other managed accounts except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder is the beneficial owner of any such securities.

SEC source: 0001781002-20-000006 · primary_doc.xml · nonDerivative · entry 1

Bleichroeder LP · CIK 0001781002 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,924,893

F1 · price: The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions. Prices ranged from $4.95 to $5.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

F2 · balance_after: Total amount of securities reported in item 5 does not include previously reported 5,000,000 of Series B Convertible Preferred shares.

F3 · ownership.nature: The shares of Common Stock reported herein are indirectly beneficially owned by Bleichroeder, LP (Bleichroeder), a Delaware limited partnership, an investment adviser registered under the Investment Advisers Act of 1940. Bleichroeder is the registered investment adviser to Biotechnology Master Fund, Ltd. as well as to 21 April Fund, LP and 21 April Fund, Ltd. (collectively, the "Funds"). The shares of Common Stock reported herein are directly held by the Funds and other managed accounts. Bleichroeder disclaims beneficial ownership of the shares of Common Stock held directly by the Funds and other managed accounts except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder is the beneficial owner of any such securities.

SEC source: 0000899243-20-002889 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,857

F1 · balance_after: Includes an aggregate of 74,063 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-20-000409 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,985

F1 · balance_after: Includes an aggregate of 74,375 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-028406 · doc4.xml · nonDerivative · entry 2

HUMPHREYS STEVEN · CIK 0001229295 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,441

SEC source: 0000899243-19-028406 · doc4.xml · nonDerivative · entry 1

HUMPHREYS STEVEN · CIK 0001229295 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,324

F1 · shares: Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vesting 100% on date of grant.

SEC source: 0000899243-19-027482 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,007

F1 · balance_after: Includes an aggregate of 76,875 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-027174 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,952

F1 · shares: Shares issuable upon settlement of a restricted stock unit award that vests as to 25% of the underlying shares on November 1, 2020 with additional vesting in equal quarterly installments over the following three years.

F2 · balance_after: Includes an aggregate of 62,500 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-026586 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,952

F1 · balance_after: Includes an aggregate of 62,500 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-024628 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,384

F1 · balance_after: Includes an aggregate of 63,750 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-023309 · doc4.xml · nonDerivative · entry 1

HUMPHREYS STEVEN · CIK 0001229295 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,768

SEC source: 0001567619-19-017897 · doc1.xml · derivative · entry 3

First Eagle Investment Management, LLC · CIK 0001325447 · 10% owner

First Eagle Holdings, Inc. · CIK 0001637141 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 2,000,000 shares

Expires not disclosed

F4 · derivative.exercise_price: See Exhibit 99.1; Note 4.

F2 · kind: See Exhibit 99.1; Note 2.

F2 · shares: See Exhibit 99.1; Note 2.

F4 · derivative.exercise_date: See Exhibit 99.1; Note 4.

F4 · derivative.expiration_date: See Exhibit 99.1; Note 4.

F4 · derivative.underlying_shares: See Exhibit 99.1; Note 4.

F2 · balance_after: See Exhibit 99.1; Note 2.

F5 · ownership.nature: See Exhibit 99.1; Note 5.

SEC source: 0001567619-19-017897 · doc1.xml · derivative · entry 2

First Eagle Investment Management, LLC · CIK 0001325447 · 10% owner

First Eagle Holdings, Inc. · CIK 0001637141 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000,000 shares

Expires not disclosed

F1 · security: See Exhibit 99.1; Note 1.

F4 · derivative.exercise_price: See Exhibit 99.1; Note 4.

F2 · kind: See Exhibit 99.1; Note 2.

F2 · shares: See Exhibit 99.1; Note 2.

F4 · derivative.exercise_date: See Exhibit 99.1; Note 4.

F4 · derivative.expiration_date: See Exhibit 99.1; Note 4.

F4 · derivative.underlying_shares: See Exhibit 99.1; Note 4.

F2 · balance_after: See Exhibit 99.1; Note 2.

SEC source: 0001567619-19-017897 · doc1.xml · nonDerivative · entry 1

First Eagle Investment Management, LLC · CIK 0001325447 · 10% owner

First Eagle Holdings, Inc. · CIK 0001637141 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F1 · security: See Exhibit 99.1; Note 1.

F2 · kind: See Exhibit 99.1; Note 2.

F2 · shares: See Exhibit 99.1; Note 2.

F2 · balance_after: See Exhibit 99.1; Note 2.

F3 · ownership.nature: See Exhibit 99.1; Note 3.

SEC source: 0000899243-19-022060 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,248

F1 · balance_after: Includes an aggregate of 66,250 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-021313 · doc4.xml · nonDerivative · entry 1

Braun Robin R. · CIK 0001778883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,220

F1 · shares: Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vesting 1/12th monthly beginning the vesting commencement date of June 1, 2019. Vested shares will be delivered to the reporting person on the earlier of (i) three years from the initial vesting start date of the award or (ii) the separation of service.

SEC source: 0000899243-19-021314 · doc4.xml · nonDerivative · entry 1

Shapiro Nina B. · CIK 0001678757 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,877

F1 · shares: Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vesting 1/12th monthly beginning the vesting commencement date of June 1, 2019. Vested shares will be delivered to the reporting person on the earlier of (i) three years from the initial vesting start date of the award or (ii) the separation of service.

SEC source: 0000899243-19-021312 · doc4.xml · nonDerivative · entry 1

OUSLEY JAMES E · CIK 0001200933 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,325

F1 · shares: Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vesting 1/12th monthly beginning the vesting commencement date of June 1, 2019. Vested shares will be delivered to the reporting person on the earlier of (i) three years from the initial vesting start date of the award or (ii) the separation of service.

SEC source: 0000899243-19-021311 · doc4.xml · nonDerivative · entry 1

KREMEN GARY · CIK 0001600778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,501

F1 · shares: Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vesting 1/12th monthly beginning the vesting commencement date of June 1, 2019. Vested shares will be delivered to the reporting person on the earlier of (i) three years from the initial vesting start date of the award or (ii) the separation of service.

SEC source: 0000899243-19-018697 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,193

F1 · balance_after: Includes an aggregate of 71,875 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-017216 · doc4.xml · nonDerivative · entry 3

HUMPHREYS STEVEN · CIK 0001229295 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,309

F1 · balance_after: Includes an aggregrate of 18,916 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-017216 · doc4.xml · nonDerivative · entry 2

HUMPHREYS STEVEN · CIK 0001229295 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,309

F1 · balance_after: Includes an aggregrate of 18,916 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-017216 · doc4.xml · nonDerivative · entry 1

HUMPHREYS STEVEN · CIK 0001229295 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,309

F1 · balance_after: Includes an aggregrate of 18,916 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-016876 · doc4.xml · nonDerivative · entry 1

KREMEN GARY · CIK 0001600778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,833

SEC source: 0000899243-19-016687 · doc4.xml · nonDerivative · entry 3

KREMEN GARY · CIK 0001600778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 218,833

SEC source: 0000899243-19-016687 · doc4.xml · nonDerivative · entry 2

KREMEN GARY · CIK 0001600778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 218,304

SEC source: 0000899243-19-016687 · doc4.xml · nonDerivative · entry 1

KREMEN GARY · CIK 0001600778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,864

SEC source: 0000899243-19-016469 · doc4.xml · nonDerivative · entry 1

HUMPHREYS STEVEN · CIK 0001229295 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,309

F1 · balance_after: Includes an aggregrate of 18,916 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-013892 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,057

F1 · balance_after: Includes an aggregate of 74,375 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-009616 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,974

F1 · balance_after: Includes an aggregate of 80,000 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-007381 · doc4.xml · nonDerivative · entry 1

HUMPHREYS STEVEN · CIK 0001229295 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,850

F1 · balance_after: Includes an aggregrate of 37,832 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

SEC source: 0000899243-19-004055 · doc4.xml · nonDerivative · entry 1

Wallach Sandra · CIK 0001698362 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,770

F1 · balance_after: Includes an aggregate of 90,000 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.